SPBC902.06 Antibody

What is SPBC902.06 and why is it relevant for yeast research?

SPBC902.06 is a protein found in Schizosaccharomyces pombe (fission yeast), which serves as an important model organism in molecular and cellular biology research. This protein is part of a family of yeast proteins that have been studied for their roles in various cellular processes. Antibodies targeting SPBC902.06 provide researchers with tools to detect, quantify, and localize this protein in experimental systems. The study of SPBC902.06 contributes to our understanding of fundamental biological processes in eukaryotic cells, as S. pombe shares many conserved cellular mechanisms with higher eukaryotes including humans. Researchers typically employ SPBC902.06 antibodies when investigating yeast cellular functions, protein-protein interactions, and when using yeast as a model system for studying homologous proteins in more complex organisms .

What are the primary applications for SPBC902.06 antibody in yeast research?

The primary applications for SPBC902.06 antibody in yeast research include Western blotting (WB) and enzyme-linked immunosorbent assay (ELISA), as indicated by the available research tools . In Western blotting, the antibody allows researchers to detect and semi-quantitatively analyze the expression levels of SPBC902.06 protein in cell lysates. This application is particularly valuable for studies involving protein expression changes under various experimental conditions, mutant analyses, and protein characterization studies. For ELISA applications, the antibody enables quantitative detection of the protein in various sample types. Additional applications that researchers might explore, though not explicitly mentioned in the search results, could include immunoprecipitation for studying protein-protein interactions, chromatin immunoprecipitation if the protein has DNA-binding properties, and immunofluorescence for subcellular localization studies in fixed yeast cells .

How should I prepare yeast samples for optimal antibody recognition of SPBC902.06?

For optimal antibody recognition of SPBC902.06 in yeast samples, researchers should follow these methodological steps:

• Cell Collection: Harvest yeast cells during the appropriate growth phase (typically mid-log phase for standard analyses) by centrifugation at 1,000-3,000 × g for 5 minutes.

• Cell Wall Disruption: Given that yeast has a tough cell wall, mechanical disruption is essential. Use either glass bead lysis (vortexing cells with glass beads in lysis buffer) or enzymatic digestion with zymolyase/lyticase to create spheroplasts.

• Lysis Buffer Selection: Prepare a lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, supplemented with protease inhibitor cocktail. The addition of phosphatase inhibitors is recommended if phosphorylation status is relevant.

• Sample Denaturation: For Western blot applications, denature proteins by heating samples in SDS-loading buffer (containing β-mercaptoethanol or DTT) at 95°C for 5 minutes. For ELISA, native protein conditions may be preferable depending on the epitope recognized by the antibody.

• Protein Quantification: Perform a Bradford or BCA assay to ensure equal loading of protein amounts across samples.

This careful sample preparation protocol ensures consistent protein extraction and preservation of the native epitopes recognized by the SPBC902.06 antibody, leading to more reliable and reproducible experimental results .

What validation methods should I use to confirm SPBC902.06 antibody specificity?

To confirm the specificity of SPBC902.06 antibody, researchers should implement a multi-tiered validation approach:

• Positive and Negative Controls: Use wild-type S. pombe strains as positive controls and SPBC902.06 deletion mutants as negative controls. The antibody should detect a band of the expected molecular weight in wild-type samples but show no signal in the deletion mutant samples.

• Peptide Competition Assay: Pre-incubate the antibody with excess purified SPBC902.06 peptide (corresponding to the immunogen) before application to your samples. Specific antibody binding should be significantly reduced or eliminated.

• Heterologous Expression: Express tagged SPBC902.06 protein in a heterologous system (e.g., E. coli or mammalian cells) and confirm detection with both the SPBC902.06 antibody and an antibody against the tag.

• Mass Spectrometry Validation: Perform immunoprecipitation with the SPBC902.06 antibody, followed by mass spectrometry analysis of the precipitated proteins to confirm the presence of SPBC902.06.

• Cross-reactivity Testing: Test the antibody against closely related proteins, particularly from the same protein family, to assess potential cross-reactivity. This is especially important when studying homologous proteins like SPBC902.04 which appears to be related .

This comprehensive validation approach ensures that experimental results generated using the SPBC902.06 antibody can be confidently attributed to the specific detection of the target protein, minimizing the risk of false positives or misleading data interpretation .

How can I determine the optimal antibody concentration for my specific application?

Determining the optimal antibody concentration for SPBC902.06 antibody requires a systematic titration approach tailored to each specific application:

For Western Blot applications:

• Prepare a dilution series of the antibody (typically starting from 1:500 to 1:10,000) while keeping all other parameters constant.

• Run identical samples of yeast lysate containing SPBC902.06 protein on multiple lanes of a gel.

• Process membranes with different antibody dilutions and evaluate signal-to-noise ratio, background levels, and specific band intensity.

• Select the highest dilution (lowest concentration) that produces a clear, specific signal with minimal background.

For ELISA applications:

• Create an antibody dilution matrix (typically 1:100 to 1:10,000) in combination with a standard curve of purified antigen or positive control samples.

• Calculate the detection limit and linear range for each antibody dilution.

• Analyze the coefficient of variation between replicates at each concentration.

• Select the dilution that provides the widest dynamic range with acceptable precision (CV < 15%) and lowest detection limit.

This methodical optimization process should be performed for each new lot of antibody received and for each distinct experimental system, as optimal concentrations may vary based on expression levels of SPBC902.06 in different yeast strains or under different experimental conditions .

What are the most common causes of false negative results when using SPBC902.06 antibody?

False negative results when using SPBC902.06 antibody can stem from multiple methodological issues:

• Epitope Masking or Destruction: The epitope recognized by the antibody may be masked due to protein folding or destroyed during sample processing. Try multiple protein extraction methods (native vs. denaturing conditions) and different detergents (Triton X-100, NP-40, CHAPS) to preserve epitope integrity.

• Insufficient Cell Lysis: Yeast cells have tough cell walls that may resist standard lysis protocols. Ensure complete lysis by extending mechanical disruption time, optimizing zymolyase/lyticase treatment, or using harsher lysis conditions while maintaining protein integrity.

• Protein Degradation: SPBC902.06 may be susceptible to proteolytic degradation during sample preparation. Always use fresh protease inhibitor cocktails and keep samples cold throughout processing. Consider adding specific inhibitors if the protein has known sensitivities.

• Antibody Deterioration: Antibodies can lose activity over time due to improper storage or handling. Store antibody aliquots at -20°C or -80°C, avoid repeated freeze-thaw cycles, and validate each new lot against a reference sample.

• Transfer Inefficiency: For Western blotting, proteins may not efficiently transfer to membranes, particularly if SPBC902.06 has unusual biochemical properties. Try different membrane types (PVDF vs. nitrocellulose) and transfer conditions (wet vs. semi-dry, varying buffer compositions).

• Post-translational Modifications: If SPBC902.06 undergoes post-translational modifications that alter the epitope, the antibody may fail to recognize the modified form. Consider using phosphatase treatment if phosphorylation is suspected to affect antibody binding.

Systematic troubleshooting of these potential issues will help identify the specific cause of false negative results and lead to protocol adjustments that improve detection reliability .

How can I reduce background signals when using SPBC902.06 antibody in Western blots?

To reduce background signals when using SPBC902.06 antibody in Western blots, implement these methodological refinements:

• Blocking Optimization: Test different blocking agents (5% non-fat milk, 3-5% BSA, commercial blocking buffers) to determine which provides optimal blocking with minimal interference with antibody binding. For yeast samples, consider using 5% BSA which may be more effective than milk for reducing non-specific binding.

• Washing Protocol Enhancement: Extend washing steps (4-5 washes of 10 minutes each) with TBS-T (0.1% Tween-20) after both primary and secondary antibody incubations. Consider increasing Tween-20 concentration to 0.2% if background persists.

• Antibody Dilution and Incubation: Further dilute the primary antibody beyond standard recommendations and incubate overnight at 4°C rather than at room temperature for shorter periods. For the secondary antibody, use a higher dilution (1:10,000 to 1:20,000) and shorter incubation time (30-60 minutes).

• Protein Sample Purification: Additional purification steps for yeast lysates, such as centrifugation at higher speeds to remove insoluble debris or passing through a 0.45 μm filter, can significantly reduce background.

• Cross-Adsorption of Secondary Antibody: If the background persists, consider using a secondary antibody that has been cross-adsorbed against yeast proteins to minimize non-specific interactions.

• Membrane Pre-Incubation: Pre-incubate the membrane with the secondary antibody host serum (e.g., 10% normal goat serum if using goat anti-rabbit secondary) before applying the primary antibody to reduce non-specific binding.

This systematic approach to reducing background signals will substantially improve the signal-to-noise ratio in Western blots, making bands specific to SPBC902.06 more clearly visible and allowing for more accurate quantification .

How can I use SPBC902.06 antibody in co-immunoprecipitation to study protein-protein interactions?

For co-immunoprecipitation (Co-IP) studies with SPBC902.06 antibody, follow this detailed methodological approach:

• Sample Preparation: Harvest yeast cells and prepare lysates under non-denaturing conditions to preserve protein-protein interactions. Use a mild lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 0.5-1% NP-40 or 0.5% Triton X-100, supplemented with protease and phosphatase inhibitors.

• Pre-clearing Step: Pre-clear the lysate by incubating with Protein A/G beads without antibody for 1 hour at 4°C with gentle rotation, then remove the beads by centrifugation. This reduces non-specific binding in the subsequent immunoprecipitation step.

• Antibody Binding: Incubate the pre-cleared lysate with SPBC902.06 antibody (typically 2-5 μg per 500 μg of total protein) overnight at 4°C with gentle rotation. In parallel, set up control samples using either non-specific IgG from the same species or lysate from SPBC902.06 deletion strains.

• Immunoprecipitation: Add pre-washed Protein A/G magnetic beads to the lysate-antibody mixture and incubate for 2-3 hours at 4°C with gentle rotation. Capture the beads using a magnetic stand and wash 4-5 times with lysis buffer containing reduced detergent concentration.

• Elution and Analysis: Elute bound proteins by boiling the beads in SDS-loading buffer or using a more gentle elution with a competing peptide. Analyze the immunoprecipitated complexes by SDS-PAGE followed by Western blotting or mass spectrometry.

• Data Validation: Confirm the presence of SPBC902.06 in the immunoprecipitated material by Western blot. Identify co-precipitated proteins using antibodies against suspected interaction partners or through mass spectrometry analysis.

• Interaction Confirmation: Validate key interactions through reciprocal Co-IP (using antibodies against the identified partners) and orthogonal methods such as yeast two-hybrid or proximity ligation assays.

This comprehensive Co-IP protocol enables researchers to identify and characterize the protein interaction network of SPBC902.06, providing insights into its functional roles within yeast cellular pathways .

What approaches should I use to compare expression levels of SPBC902.06 across different experimental conditions?

To accurately compare SPBC902.06 expression levels across different experimental conditions, implement this systematic quantitative approach:

• Experimental Design:

  • Include biological replicates (minimum n=3) for each condition

  • Process all samples in parallel to minimize technical variation

  • Include a reference condition in each experiment for normalization

• Sample Processing for Western Blot Analysis:

  • Extract total protein using a consistent protocol across all samples

  • Quantify protein concentration using Bradford or BCA assay

  • Load equal amounts of total protein (15-30 μg) per lane

  • Include ladder markers and a common reference sample on each gel

• Electrophoresis and Transfer Optimization:

  • Use gradient gels (4-15%) for optimal resolution

  • Implement consistent transfer conditions with verification (e.g., Ponceau S staining)

• Immunodetection Protocol:

  • Block membranes using standardized conditions

  • Apply SPBC902.06 antibody at optimized dilution

  • Simultaneously probe for loading control protein (e.g., actin, GAPDH, or total protein using stain-free technology)

  • Use secondary antibodies with fluorescent tags for linear quantification

• Quantification Methodology:

  • Capture images using a digital imaging system within the linear range of detection

  • Measure band intensities using image analysis software (ImageJ, Image Lab)

  • Normalize SPBC902.06 signal to loading control

• Data Analysis and Statistical Evaluation:

  • Calculate relative expression levels using the formula:
    Relative expression = (SPBC902.06 intensity / Loading control intensity) / (Reference condition ratio)

  • Apply appropriate statistical tests (ANOVA with post-hoc tests for multiple conditions)

  • Present data as fold change relative to control condition

• Alternative Approaches for Verification:

  • Quantitative ELISA assays for absolute quantification

  • RT-qPCR analysis of SPBC902.06 mRNA levels

  • Mass spectrometry-based proteomics with isotope labeling (SILAC, TMT)

This rigorous methodological framework ensures reliable and reproducible quantification of SPBC902.06 expression changes across experimental conditions, enabling confident interpretation of results from treatment effects, genetic modifications, or environmental perturbations .

How can I use SPBC902.06 antibody for immunofluorescence microscopy in yeast cells?

For successful immunofluorescence microscopy using SPBC902.06 antibody in yeast cells, follow this detailed protocol addressing the unique challenges of yeast cell architecture:

• Cell Wall Digestion and Fixation:

  • Harvest yeast cells in mid-log phase (OD600 = 0.5-0.8)

  • Treat with zymolyase/lyticase in sorbitol buffer (1.2 M sorbitol, 50 mM potassium phosphate, pH 7.5) for 30-45 minutes at 30°C to create spheroplasts

  • Fix cells with 4% paraformaldehyde in PBS for 30 minutes at room temperature

  • For improved epitope accessibility, consider double fixation with formaldehyde followed by methanol

• Slide Preparation and Cell Adherence:

  • Coat microscope slides with poly-L-lysine (0.1% solution) to improve cell adherence

  • Apply fixed spheroplasts to slides and allow them to settle for 20 minutes

  • Gently remove excess liquid without disturbing the attached cells

• Permeabilization and Blocking:

  • Permeabilize cells with 0.1% Triton X-100 in PBS for 10 minutes

  • Block with 3% BSA, 0.1% Tween-20 in PBS for 1 hour at room temperature

• Antibody Incubation:

  • Apply primary SPBC902.06 antibody at optimized dilution (typically 1:100 to 1:500) in blocking buffer

  • Incubate in a humid chamber overnight at 4°C

  • Wash extensively (5 × 5 minutes) with PBS containing 0.1% Tween-20

  • Apply fluorophore-conjugated secondary antibody (1:500 to 1:1000) for 1 hour at room temperature in the dark

  • Wash as above, protecting from light

• Nuclear Counterstaining and Mounting:

  • Counterstain nuclei with DAPI (1 μg/ml) for 5 minutes

  • Mount with anti-fade mounting medium

  • Seal coverslips with nail polish and store at 4°C in the dark

• Imaging and Analysis:

  • Capture images using confocal or wide-field fluorescence microscopy

  • Include controls: secondary-only control, wild-type cells, and SPBC902.06 deletion strains

  • Analyze subcellular localization patterns using appropriate imaging software

• Co-localization Studies:

  • For co-localization experiments, include antibodies against known subcellular markers

  • Consider fluorescence resonance energy transfer (FRET) analysis for proteins in close proximity

This comprehensive protocol addresses the challenging aspects of yeast immunofluorescence microscopy, enabling researchers to visualize the subcellular localization of SPBC902.06 and its potential co-localization with other proteins of interest .

What considerations are important when using SPBC902.06 antibody for chromatin immunoprecipitation (ChIP) experiments?

For effective chromatin immunoprecipitation (ChIP) experiments using SPBC902.06 antibody, follow these specialized methodological considerations:

• Chromatin Preparation:

  • Crosslink yeast cells with 1% formaldehyde for 15-20 minutes at room temperature

  • Quench excess formaldehyde with 125 mM glycine for 5 minutes

  • Lyse cells using glass bead disruption in lysis buffer (50 mM HEPES-KOH pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate) with protease inhibitors

  • Isolate chromatin and shear to 200-500 bp fragments using sonication or enzymatic digestion

• Antibody Validation for ChIP:

  • Verify SPBC902.06 antibody specificity through ChIP in wild-type versus deletion strains

  • Perform a pilot experiment with increasing antibody amounts (1-10 μg) to determine optimal concentration

  • Consider epitope accessibility in the crosslinked chromatin context - test different epitope targeting antibodies if available

• Immunoprecipitation Protocol:

  • Pre-clear chromatin with Protein A/G beads for 1 hour at 4°C

  • Incubate pre-cleared chromatin with optimized amount of SPBC902.06 antibody overnight at 4°C

  • Include negative controls: IgG control and input chromatin samples

  • Add pre-blocked Protein A/G beads and incubate for 2-3 hours at 4°C

  • Perform stringent washing series (low salt, high salt, LiCl, and TE buffers)

• DNA Recovery and Analysis:

  • Reverse crosslinks by heating at 65°C overnight

  • Treat with RNase A and Proteinase K

  • Purify DNA using phenol-chloroform extraction or commercial kits

  • Quantify enrichment by qPCR targeting suspected binding regions

• ChIP-seq Considerations:

  • Prepare libraries with adequate controls (input, IgG ChIP)

  • Sequence to sufficient depth (minimum 10-20 million reads)

  • Analyze data using appropriate peak calling algorithms (MACS2, HOMER)

  • Validate key binding sites by ChIP-qPCR

• Interpretation Challenges:

  • Consider indirect DNA association through protein complexes

  • Validate direct binding with electrophoretic mobility shift assays (EMSA)

  • Correlate binding sites with gene expression changes in SPBC902.06 mutants

• Optimization for Low Abundance Factors:

  • If SPBC902.06 is low abundance, consider using larger culture volumes

  • Implement dual crosslinking with disuccinimidyl glutarate (DSG) followed by formaldehyde

  • Use higher sensitivity detection methods like ChIP-exo or CUT&RUN

This detailed ChIP protocol addresses the specific challenges associated with studying DNA-protein interactions involving SPBC902.06, enabling researchers to identify genomic binding sites and investigate its potential role in transcriptional regulation or chromatin organization .

How can I ensure specificity when studying SPBC902.06 versus closely related proteins like SPBC902.04?

To ensure specificity when studying SPBC902.06 versus closely related proteins like SPBC902.04, implement these rigorous discrimination strategies:

• Epitope Selection and Antibody Validation:

  • Analyze protein sequence alignments to identify unique regions in SPBC902.06 that differ from SPBC902.04

  • Select antibodies raised against these unique epitopes or peptide sequences

  • Validate antibody specificity using recombinant proteins or lysates from strains expressing only one of the related proteins

  • Perform peptide competition assays with synthetic peptides corresponding to both SPBC902.06 and SPBC902.04 epitopes

• Experimental Controls:

  • Include knockout/deletion strains for both SPBC902.06 and SPBC902.04 as negative controls

  • Use strains with epitope-tagged versions of each protein (e.g., SPBC902.06-GFP and SPBC902.04-HA) to verify antibody specificity

  • Create standard curves with purified recombinant proteins to determine cross-reactivity thresholds

• Molecular Weight Differentiation:

  • Optimize gel resolution to separate proteins based on molecular weight differences

  • Use high-percentage or gradient gels for improved separation

  • Consider 2D gel electrophoresis to separate proteins based on both molecular weight and isoelectric point

• Cross-Reactivity Assessment Matrix:

• Alternative Approaches:

  • Implement immunodepletion techniques: pre-absorb antibody with recombinant SPBC902.04 to remove cross-reactive antibodies

  • Consider using RNA interference or CRISPR techniques to selectively deplete each protein

  • Develop mass spectrometry-based approaches for unambiguous protein identification

• Data Interpretation Guidelines:

  • Always include appropriate controls in each experiment

  • Report antibody validation evidence alongside experimental results

  • Consider biological context when interpreting results (e.g., expression patterns, subcellular localization)

This comprehensive approach ensures reliable discrimination between SPBC902.06 and related proteins, minimizing the risk of misattributing biological functions due to antibody cross-reactivity .

What experimental approaches can help distinguish functional redundancy versus unique functions between SPBC902.06 and related proteins?

To distinguish functional redundancy versus unique functions between SPBC902.06 and related proteins like SPBC902.04, implement these systematic experimental approaches:

• Genetic Manipulation Strategies:

  • Create single and double deletion mutants (SPBC902.06Δ, SPBC902.04Δ, and SPBC902.06Δ SPBC902.04Δ)

  • Analyze growth phenotypes under various conditions (temperature sensitivity, cell wall stressors, DNA damage agents)

  • Quantify genetic interaction using SGA (Synthetic Genetic Array) or E-MAP (Epistatic Mini Array Profile) approaches

  • Implement conditional expression systems to control the timing of gene expression

• Phenotypic Analysis Framework:

• Complementation Testing:

  • Express SPBC902.04 from SPBC902.06 promoter in SPBC902.06Δ strains and vice versa

  • Quantify the degree of phenotypic rescue

  • Create chimeric proteins with swapped domains to identify functionally important regions

• Protein Interaction Network Analysis:

  • Perform immunoprecipitation with SPBC902.06 antibody followed by mass spectrometry

  • Compare interaction partners between SPBC902.06 and SPBC902.04

  • Identify shared versus unique interactors

  • Use proximity labeling techniques (BioID, APEX) to map local protein environments

• Expression Pattern Comparison:

  • Analyze mRNA expression using RT-qPCR across different conditions and cell cycle stages

  • Study protein expression using specific antibodies against each protein

  • Create fluorescent protein fusions to visualize subcellular localization and expression dynamics

• Biochemical Activity Characterization:

  • Purify recombinant proteins and compare their enzymatic activities

  • Determine substrate specificities and kinetic parameters

  • Analyze post-translational modifications using phospho-specific antibodies or mass spectrometry

• Evolutionary Conservation Analysis:

  • Compare orthologs across different yeast species

  • Analyze selection pressure on different protein domains

  • Reconstruct the evolutionary history of gene duplication events

This comprehensive experimental framework enables researchers to systematically dissect the functional relationships between SPBC902.06 and related proteins, distinguishing between truly redundant functions and seemingly similar proteins that have evolved distinct specialized roles in cellular processes .

How can I integrate SPBC902.06 antibody data with other -omics datasets for comprehensive pathway analysis?

To effectively integrate SPBC902.06 antibody data with other -omics datasets for comprehensive pathway analysis, implement this systematic multi-dimensional approach:

• Data Collection and Standardization:

  • Generate protein expression/localization data using SPBC902.06 antibody across relevant conditions

  • Collect complementary datasets: transcriptomics (RNA-seq), proteomics, metabolomics, and genetic interaction data

  • Normalize all datasets using appropriate methods (e.g., Z-score normalization, quantile normalization)

  • Implement consistent sample identifiers and metadata across all experiments

• Multi-omics Integration Framework:

• Computational Integration Methods:

  • Implement correlation networks connecting SPBC902.06 expression with gene/protein modules

  • Apply dimensionality reduction techniques (PCA, t-SNE, UMAP) to visualize multi-dimensional relationships

  • Use Bayesian network inference to model causal relationships

  • Implement machine learning approaches to identify predictive patterns

• Pathway Mapping and Enrichment Analysis:

  • Map SPBC902.06 and its interactors to known pathways using KEGG, Reactome, or GO databases

  • Perform gene set enrichment analysis (GSEA) on integrated datasets

  • Identify significantly enriched biological processes and molecular functions

  • Create custom pathway visualizations highlighting SPBC902.06 connections

• Network Analysis Approaches:

  • Calculate network centrality measures to assess SPBC902.06 importance

  • Identify network modules using community detection algorithms

  • Perform differential network analysis between conditions

  • Validate key network connections experimentally

• Validation and Hypothesis Testing:

  • Prioritize key nodes for experimental validation

  • Design targeted experiments to test computational predictions

  • Implement perturbation studies to validate causal relationships

  • Create simplified models for mechanistic testing

• Data Visualization and Interpretation:

  • Develop interactive visualizations of integrated networks

  • Create comprehensive pathway diagrams highlighting multi-omics evidence

  • Implement data dashboards for exploring relationships across datasets

  • Formulate testable hypotheses based on integrated analysis

This comprehensive integration framework enables researchers to position SPBC902.06 within its broader biological context, revealing its connections to cellular pathways and generating hypotheses about its functional roles that can be experimentally validated .

What bioinformatic tools are most effective for predicting SPBC902.06 function based on structural features and conservation patterns?

For effective prediction of SPBC902.06 function based on structural features and conservation patterns, researchers should implement this multi-layered bioinformatic analysis pipeline:

• Sequence Analysis and Homology Detection:

  • Perform sensitive sequence similarity searches using PSI-BLAST, HHpred, and HMMER against reference databases

  • Identify orthologs across species using OrthoFinder or OrthoMCL

  • Detect remote homologs using profile-profile comparisons via HHsearch

  • Calculate evolutionary conservation scores using ConSurf or Rate4Site

• Domain Architecture Analysis:

  • Identify conserved domains using InterProScan, SMART, and Pfam

  • Map domain boundaries and linker regions

  • Compare domain architecture with proteins of known function

  • Analyze domain fusion events that may indicate functional associations

• Structural Prediction and Analysis:

  • Generate 3D structural models using AlphaFold2 or RoseTTAFold

  • Validate model quality using MolProbity and QMEAN

  • Identify potential binding pockets using CASTp or fpocket

  • Perform structural similarity searches using DALI or TM-align

• Function Prediction Framework:

• Evolutionary Analysis:

  • Construct multiple sequence alignments of orthologs using MAFFT or T-Coffee

  • Build phylogenetic trees using RAxML or IQ-TREE

  • Analyze substitution rates and selection pressure using PAML

  • Identify co-evolving residues using CAPS or EVcouplings

• Integrative Functional Annotation:

  • Combine evidence from multiple prediction methods using weighted schemes

  • Calculate consensus predictions with confidence scores

  • Incorporate experimental data from related proteins

  • Map predictions to testable hypotheses

• Experimental Validation Design:

  • Identify key residues for site-directed mutagenesis

  • Design truncation constructs based on predicted domains

  • Propose specific assays to test predicted functions

  • Prioritize experiments based on prediction confidence

This comprehensive bioinformatic analysis pipeline provides researchers with a systematic framework for predicting SPBC902.06 function, generating specific hypotheses that can be experimentally validated using the SPBC902.06 antibody and other molecular biology techniques. The integration of multiple computational approaches significantly increases the reliability of functional predictions compared to any single method .